Detalhe da pesquisa
1.
[Neuropsychological and MRI diagnostics in secondary progressive multiple sclerosis]. / Neuropsychologische und Magnetresonanztomographie(MRT)-Diagnostik bei sekundär progredienter Multipler Sklerose.
Nervenarzt
; 92(12): 1293-1301, 2021 Dec.
Artigo
em Alemão
| MEDLINE | ID: mdl-33891150
2.
Baseline predictors of persistence to first disease-modifying treatment in multiple sclerosis.
Acta Neurol Scand
; 136(2): 116-121, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27796033
3.
Drug-resistant MS spasticity treatment with Sativex(®) add-on and driving ability.
Acta Neurol Scand
; 131(1): 9-16, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25208898
4.
Design of T-cell receptor libraries with diverse binding properties to examine adoptive T-cell responses.
Gene Ther
; 20(6): 634-44, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23052828
5.
Single-chain VαVß T-cell receptors function without mispairing with endogenous TCR chains.
Gene Ther
; 19(4): 365-74, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21753797
6.
Selection of macrophage-resistant progressor tumor variants by the normal host. Requirement for concomitant T cell-mediated immunity.
J Exp Med
; 157(2): 642-56, 1983 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-6185615
7.
Tumor necrosis factor/cachectin. Induction of hemorrhagic necrosis in normal tissue requires the fifth component of complement (C5).
J Exp Med
; 168(6): 2007-21, 1988 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-3199066
8.
A tumor escape variant that has lost one major histocompatibility complex class I restriction element induces specific CD8+ T cells to an antigen that no longer serves as a target.
J Exp Med
; 178(3): 933-40, 1993 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-8394406
9.
Inhibition of tumor growth by elimination of granulocytes.
J Exp Med
; 181(1): 435-40, 1995 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-7807024
10.
Immunoselection of tumor cell variants by mice suppressed with ultraviolet radiation.
J Exp Med
; 156(4): 1025-41, 1982 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-7153707
11.
Loss of tumor-specific and idiotype-specific immunity with age.
J Exp Med
; 154(2): 275-90, 1981 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-6973599
12.
Tumor antigens defined by cloned immunological probes are highly polymorphic and are not detected on autologous normal cells.
J Exp Med
; 170(1): 217-32, 1989 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-2787379
13.
Identification of a unique tumor antigen as rejection antigen by molecular cloning and gene transfer.
J Exp Med
; 164(5): 1516-30, 1986 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-3490532
14.
Stroma is critical for preventing or permitting immunological destruction of antigenic cancer cells.
J Exp Med
; 175(1): 139-46, 1992 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-1309851
15.
Suppression by autogenous complementary idiotypes: the priority of the first response.
J Exp Med
; 144(4): 946-59, 1976 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-62017
16.
Mechanisms of syngeneic tumor rejection. Susceptibility of host-selected progressor variants to various immunological effector cells.
J Exp Med
; 155(2): 557-73, 1982 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-6977009
17.
Animals bearing malignant grafts reject normal grafts that express through gene transfer the same antigen.
J Exp Med
; 171(4): 1205-20, 1990 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-2324687
18.
Multiple cancers. Tumor burden permits the outgrowth of other cancers.
J Exp Med
; 162(5): 1665-82, 1985 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-3877140
19.
Highly malignant tumor variants retain tumor-specific antigens recognized by T helper cells.
J Exp Med
; 164(5): 1547-65, 1986 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-2945891
20.
Antigenic cancer cells grow progressively in immune hosts without evidence for T cell exhaustion or systemic anergy.
J Exp Med
; 186(2): 229-38, 1997 Jul 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-9221752